Cargando…
Updates of cancer hallmarks in patients with inborn errors of immunity
The development of cancer in patients with genetically determined inborn errors of immunity (IEI) is much higher than in the general population. The hallmarks of cancer are a conceptualization tool that can refine the complexities of cancer development and pathophysiology. Each genetic defect may im...
Autores principales: | Wang, Yating, Abolhassani, Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612729/ https://www.ncbi.nlm.nih.gov/pubmed/36165433 http://dx.doi.org/10.1097/ACI.0000000000000863 |
Ejemplares similares
-
Global immunoglobulin supply: steaming towards the iceberg?
por: Prevot, Johan, et al.
Publicado: (2020) -
Antibody therapy for COVID-19
por: Hammarström, Lennart, et al.
Publicado: (2021) -
Immunodeficient patient experience of emergency switch from intravenous to rapid push subcutaneous immunoglobulin replacement therapy during coronavirus disease 2019 shielding
por: Morgan, Clare, et al.
Publicado: (2022) -
Dendritic cell analysis in primary immunodeficiency
por: Bigley, Venetia, et al.
Publicado: (2016) -
Transition of care in inborn errors of immunity
por: Tadros, Susan, et al.
Publicado: (2023)